Recent collaborations with Pfizer, GlaxoSmithKline and Merck focus on the development of companion diagnostic checks for make use of in selecting individuals for novel oncology therapeutics. About the Abbott m2000 RealTime Program With more than 1,200 global placements, Abbott’s automated molecular diagnostics program, the m2000 System, utilizes real-time polymerase chain response technology for detecting and monitoring infectious diseases and was created to provide scientific laboratories a distinctive system that fully automates all the complex and greatly manual steps often connected with molecular diagnostics.The group utilized data from the 2002 Crash Final result Data Evaluation System * for Wisconsin. They studied 23,920 crash occupants, age range 16 and over, who were treated in hospital-based emergency departments ‘s, statewide in 2002, and compared ED characteristics and outcomes of seatbelt users with non users. Their study shows up in the March 10, online problem of Academic Emergency Medicine. Related StoriesCHOP's Buerger Middle for Advanced Pediatric Treatment celebrates grand openingFirst hospital installs Ortho Eyesight AnalyzerNew UCLA study talks about primary care medical home in reducing childrens' repeat appointments to hospitals’Unbelted crash occupants represented 68 % of the patients dying in the ED’s,’ says lead author Shane Allen, a third season medical student.